PHARMACEUTICAL COMPOSITION

To provide a pharmaceutical composition containing as an active ingredient a novel imidazole compound or pharmacologically acceptable salt thereof having melanocortin receptor agonist activity.SOLUTION: A pharmaceutical composition contains an imidazole compound represented by general formula [I] or...

Full description

Saved in:
Bibliographic Details
Main Authors TANIMOTO KOICHI, YAMAMOTO KOO, NAKANE SATORU, SATO ATSUSHI, IMASHIRO RITSUO, TOSHIKAWA CHIHIRO, TSUJIJIMA SHUICHI
Format Patent
LanguageEnglish
Japanese
Published 20.12.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To provide a pharmaceutical composition containing as an active ingredient a novel imidazole compound or pharmacologically acceptable salt thereof having melanocortin receptor agonist activity.SOLUTION: A pharmaceutical composition contains an imidazole compound represented by general formula [I] or a pharmacologically acceptable salt thereof as an active ingredient. [In the formula, ring A represents an optionally substituted aryl group or the like; Rrepresents a hydrogen atom, an optionally substituted alkyl group, or the like; Rrepresents a hydrogen atom, a halogen atom, or the like; and Rrepresents an optionally substituted alkyl group.]SELECTED DRAWING: None 【課題】 メラノコルチン受容体作動活性を有する新規イミダゾール化合物又はその薬理的に許容し得る塩を有効成分として含んでなる医薬組成物の提供。【解決手段】 一般式〔I〕〔式中、環Aは置換されていてもよいアリール基等を表し;R1は水素原子、置換されていてもよいアルキル基等を表し;R2は水素原子、ハロゲン原子等を表し;R3は置換されていてもよいアルキル基を表す〕で示されるイミダゾール化合物、又はその薬理的に許容し得る塩を有効成分として含んでなる医薬組成物。【選択図】 なし
AbstractList To provide a pharmaceutical composition containing as an active ingredient a novel imidazole compound or pharmacologically acceptable salt thereof having melanocortin receptor agonist activity.SOLUTION: A pharmaceutical composition contains an imidazole compound represented by general formula [I] or a pharmacologically acceptable salt thereof as an active ingredient. [In the formula, ring A represents an optionally substituted aryl group or the like; Rrepresents a hydrogen atom, an optionally substituted alkyl group, or the like; Rrepresents a hydrogen atom, a halogen atom, or the like; and Rrepresents an optionally substituted alkyl group.]SELECTED DRAWING: None 【課題】 メラノコルチン受容体作動活性を有する新規イミダゾール化合物又はその薬理的に許容し得る塩を有効成分として含んでなる医薬組成物の提供。【解決手段】 一般式〔I〕〔式中、環Aは置換されていてもよいアリール基等を表し;R1は水素原子、置換されていてもよいアルキル基等を表し;R2は水素原子、ハロゲン原子等を表し;R3は置換されていてもよいアルキル基を表す〕で示されるイミダゾール化合物、又はその薬理的に許容し得る塩を有効成分として含んでなる医薬組成物。【選択図】 なし
Author NAKANE SATORU
SATO ATSUSHI
YAMAMOTO KOO
TOSHIKAWA CHIHIRO
TSUJIJIMA SHUICHI
TANIMOTO KOICHI
IMASHIRO RITSUO
Author_xml – fullname: TANIMOTO KOICHI
– fullname: YAMAMOTO KOO
– fullname: NAKANE SATORU
– fullname: SATO ATSUSHI
– fullname: IMASHIRO RITSUO
– fullname: TOSHIKAWA CHIHIRO
– fullname: TSUJIJIMA SHUICHI
BookMark eNrjYmDJy89L5WSQCvBwDPJ1dHYNDfF0dvRRcPb3DfAP9gzx9PfjYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxXgFGBoYWhpaWZubGjsZEKQIAXwsixg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 医薬組成物
ExternalDocumentID JP2018199673A
GroupedDBID EVB
ID FETCH-epo_espacenet_JP2018199673A3
IEDL.DBID EVB
IngestDate Fri Jul 19 16:20:41 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Japanese
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_JP2018199673A3
Notes Application Number: JP20180100327
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181220&DB=EPODOC&CC=JP&NR=2018199673A
ParticipantIDs epo_espacenet_JP2018199673A
PublicationCentury 2000
PublicationDate 20181220
PublicationDateYYYYMMDD 2018-12-20
PublicationDate_xml – month: 12
  year: 2018
  text: 20181220
  day: 20
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies MITSUBISHI TANABE PHARMA CORP
RelatedCompanies_xml – name: MITSUBISHI TANABE PHARMA CORP
Score 3.3023202
Snippet To provide a pharmaceutical composition containing as an active ingredient a novel imidazole compound or pharmacologically acceptable salt thereof having...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PHARMACEUTICAL COMPOSITION
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181220&DB=EPODOC&locale=&CC=JP&NR=2018199673A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTEwTjFPNkvVtUgyMtY1MUqy0E20sEzWBZ3MnmiQlmSaBr46wdfPzCPUxCvCNIKJIRu2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHoOrKyEDNxcnWNcDfxd9ZzdnZ1itAzS8IIgds25sbOzIzsALb0eag9V-uYU6gbSkFyHWKmyADWwDQuLwSIQamrERhBk5n2NVrwgwcvtAZbyATmvmKRRikAjwcg3wdnV1DQ0CHGCg4-_sG-Ad7gsaYRBmU3FxDnD10gZbEw70U7xWA5CBjMQYWYF8_VYJBIS3ZxMQy1dIgxdw4xcQ0yTApxTIxLS3FItk8DVjPp1pKMkjjMUgKr6w0AxeIB1qLYWQgw8BSUlSaKgusUUuS5MAhAQA87HbG
link.rule.ids 230,309,783,888,25578,76886
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTEwTjFPNkvVtUgyMtY1MUqy0E20sEzWBZ3MnmiQlmSaBr46wdfPzCPUxCvCNIKJIRu2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHoOrKyEDNxcnWNcDfxd9ZzdnZ1itAzS8IIgds25sbOzIzsALb2Bag7OAa5gTallKAXKe4CTKwBQCNyysRYmDKShRm4HSGXb0mzMDhC53xBjKhma9YhEEqwMMxyNfR2TU0BHSIgYKzv2-Af7AnaIxJlEHJzTXE2UMXaEk83EvxXgFIDjIWY2AB9vVTJRgU0pJNTCxTLQ1SzI1TTEyTDJNSLBPT0lIsks3TgPV8qqUkgzQeg6TwysozcHqE-PrE-3j6eUszcIFkQOsyjAxkGFhKikpTZYG1a0mSHDhUAPhLebg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PHARMACEUTICAL+COMPOSITION&rft.inventor=TANIMOTO+KOICHI&rft.inventor=YAMAMOTO+KOO&rft.inventor=NAKANE+SATORU&rft.inventor=SATO+ATSUSHI&rft.inventor=IMASHIRO+RITSUO&rft.inventor=TOSHIKAWA+CHIHIRO&rft.inventor=TSUJIJIMA+SHUICHI&rft.date=2018-12-20&rft.externalDBID=A&rft.externalDocID=JP2018199673A